A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
List view / Grid view
University of Texas MD Anderson Cancer Center
Filter the results
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...